Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart PumpPR Newswire
Kaldalón hf.: Sala nýjum skuldabréfaflokki KALD 150129GlobeNewswire
Ölgerðin Egill Skallagrímsson hf.: Kaupréttaráætlun fyrir starfsfólk Ölgerðarinnar og dótturfélagaGlobeNewswire
Lens Technology and Rokid Usher in a New Era for AR: A Synergy of Innovation and Ecosystem IntegrationEQS Newswire
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025GlobeNewswire
New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CMBusiness Wire
EQS-NVR: Adtran Holdings, Inc.: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionEQS Newswire
Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseasGlobeNewswire
Gold Reserve Provides Update on U.S. Government’s Statement of Interest Supporting Venezuelan Opposition Government in Litigation Regarding Validity of 2020 PDVSA BondsBusiness Wire
Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled HypertensionBusiness Wire
RNS announcements are delayed by up to an hour.
...